[ExI] Early Data Indicates an A.I.-Generated Drug Could Slow Aging
Stuart LaForge
avant at sollegro.com
Wed Sep 9 03:56:35 UTC 2026
If that is so then patent law and copyright are diverging. There was a
recent case regarding a graphic novel titled "Zarya of the Dawn" that
only got limited copyright protection from the USPTO because the author
Kris Kashtanova used Midjourney for the artwork. The layout and text
were copyrightable, but the images were not. Also, I think that many if
not most people choose not to distinguish between good AI-assisted art
and AI slop, which is the difference between useful information and
spam. There is a weird irrational element to the politics surrounding
generative AI. The irrationality is a little reminiscent of "The
Animatrix" prequel to "The Matrix" movie where the all human nations
boycotted importing products from the machine nation because it was of
higher quality than the human products.
Stuart LaForge
On 2026-09-08 13:54, Jason Resch via extropy-chat wrote:
> My understanding is they can still patent it, just that they must list
> only human names on the patent application where it asks for
> inventors.
>
> There was an AI called the "invention machine" a few decades ago that
> used genetic programming algorithms to find novel designs, which were
> subsequently patented.
>
> What or methods were used to help find a certain technique or drug
> isn't asked for on a patent applications today, and I suppose the
> person who supplied the prompt could put their name down as the
> inventor.
>
> Most journals are following a similar direction, they don't allow
> adding AIs as authors even when they contribute substantially or more
> than any human coauthor.
>
> Jason
>
> On Tue, Sep 8, 2026, 12:25 PM Stuart LaForge via extropy-chat
> <extropy-chat at lists.extropy.org> wrote:
>
>> I am not against using AI to invent and generate intellectual
>> property,
>> but I wonder how the laws against it will affect things like drug
>> development. I mean big pharma typically won't make a drug to combat
>> a
>> disease unless they can patent it. Are they going to make an
>> exception
>> in the new AI laws for large corporations?
>>
>> Stuart LaForge
>>
>> On 2026-09-07 12:25, John Clark via extropy-chat wrote:
>>> Explore this gift article from The New York Times. You can read it
>> for
>>> free without a subscription.
>>>
>>> Early Data Indicates an A.I.-Generated Drug Could Slow Aging
>>>
>>> Artificial intelligence was used to help develop a drug candidate,
>>> rentosertib, for a rare lung condition. Its maker says the drug
>> also
>>> seems to reduce the biological hallmarks of age.
>>>
>>>
>>
> https://www.nytimes.com/2026/09/07/science/ai-generated-drug-longevity.html?unlocked_article_code=1._VA.LFye.Rv2JHNLQdgzL&smid=em-share
>> [1]
>>> [1]
>>>
>>> Links:
>>> ------
>>> [1]
>>>
>>
> https://www.nytimes.com/2026/09/07/science/ai-generated-drug-longevity.html?unlocked_article_code=1._VA.LFye.Rv2JHNLQdgzL&smid=em-share
>> [1]
>>> _______________________________________________
>>> extropy-chat mailing list
>>> extropy-chat at lists.extropy.org
>>> http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat
>> _______________________________________________
>> extropy-chat mailing list
>> extropy-chat at lists.extropy.org
>> http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat
>
>
> Links:
> ------
> [1]
> https://www.nytimes.com/2026/09/07/science/ai-generated-drug-longevity.html?unlocked_article_code=1._VA.LFye.Rv2JHNLQdgzL&smid=em-share
> _______________________________________________
> extropy-chat mailing list
> extropy-chat at lists.extropy.org
> http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat
More information about the extropy-chat
mailing list